VS

Vedprakash Shantalingappa Ragate

Director Director DIN 10578409
DIN 10578409 First appointment Apr 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 3 historical roles
Total affiliations 3 Since Apr 2024
Shareholding value •••• Premium profile

About Vedprakash Shantalingappa Ragate

Data last updated:

Vedprakash Shantalingappa Ragate was a Director at Alivira Animal Health Limited (2024–2025), Whole-Time Director at Sequent Scientific Limited (2024–2025) and Director at Sequent Research Limited (from 2024). The companies operate in Pharma and Chemicals.

DIN 10578409
Primary Designation Director
Industry Pharma
First Appointment 06 Apr 2024
Oldest Company Age 19 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alivira Animal Health Limited U74120MH2013PLC248708
Director06 Apr 20242013₹393 Cr (FY 2025)Active
Sequent Scientific Limited L99999TS1985PLC196357
Whole-Time Director17 Apr 20241985₹3,464 Cr (FY 2026)Active
Sequent Research Limited U24232TS2007PLC196886
Director11 Apr 20242007₹9.52 Cr (FY 2025)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sequent Research Limited
Alivira Animal Health Limited
Sequent Scientific Limited
Premium access

Shareholding and investment profile for Vedprakash Shantalingappa Ragate

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vedprakash Shantalingappa Ragate

Vedprakash Shantalingappa Ragate was first appointed on 06 Apr 2024 as Director at Alivira Animal Health Limited.

Vedprakash Shantalingappa Ragate held 3 earlier board appointments: Alivira Animal Health Limited (Director, 06 Apr 2024 to 30 Sep 2025); Sequent Scientific Limited (Whole-Time Director, 17 Apr 2024 to 30 Sep 2025); Sequent Research Limited (Director, from 11 Apr 2024).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available